MOESM6 of Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer
收藏DataCite Commons2020-08-26 更新2024-07-27 收录
下载链接：
https://springernature.figshare.com/articles/MOESM6_of_Combination_of_mTORC1_2_inhibitor_vistusertib_plus_fulvestrant_in_vitro_and_in_vivo_targets_oestrogen_receptor-positive_endocrine-resistant_breast_cancer/11321036
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 6: File S1. Ingenuity pathway analysis of the HBCx34 OvaR PDX models at the end of the study.
补充材料6：文件S1。研究结束时针对HBCx34 OvaR 患者来源的异种移植（Patient-Derived Xenograft，PDX）模型开展的Ingenuity通路分析（Ingenuity Pathway Analysis）。
提供机构：
figshare
创建时间：
2019-12-05
